| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 29/11/2024 | 21:54 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:MRNA | Moderna Inc |
| 12/11/2024 | 22:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MRNA | Moderna Inc |
| 08/11/2024 | 13:30 | PR Newswire (US) | Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma | NASDAQ:MRNA | Moderna Inc |
| 07/11/2024 | 22:03 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:MRNA | Moderna Inc |
| 07/11/2024 | 12:33 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MRNA | Moderna Inc |
| 07/11/2024 | 12:19 | IH Market News | U.S. Futures Rise as Investors Await Fed Rate Decision; Oil Prices Drop | NASDAQ:MRNA | Moderna Inc |
| 06/11/2024 | 12:09 | IH Market News | Trump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%; Coinbase Rises with BTC All-Time High | NASDAQ:MRNA | Moderna Inc |
| 05/11/2024 | 15:05 | PR Newswire (US) | Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 | NASDAQ:MRNA | Moderna Inc |
| 28/10/2024 | 11:45 | Business Wire | Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC) | NASDAQ:MRNA | Moderna Inc |
| 23/10/2024 | 14:00 | PR Newswire (US) | Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence | NASDAQ:MRNA | Moderna Inc |
| 07/10/2024 | 11:45 | PR Newswire (US) | Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA | NASDAQ:MRNA | Moderna Inc |
| 04/10/2024 | 14:49 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:MRNA | Moderna Inc |
| 03/10/2024 | 14:00 | PR Newswire (US) | Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors | NASDAQ:MRNA | Moderna Inc |
| 30/09/2024 | 11:45 | PR Newswire (US) | MRNA LAWSUIT ALERT: The Gross Law Firm Notifies Moderna, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NASDAQ:MRNA | Moderna Inc |
| 26/09/2024 | 11:45 | PR Newswire (US) | Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact The Gross Law Firm to Learn More | NASDAQ:MRNA | Moderna Inc |
| 23/09/2024 | 11:45 | PR Newswire (US) | Moderna, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA | NASDAQ:MRNA | Moderna Inc |
| 19/09/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA | NASDAQ:MRNA | Moderna Inc |
| 13/09/2024 | 12:12 | IH Market News | OpenAI Unveils Strawberry AI Model Series; Boeing Stock Falls 4% Amid Strike; HR Surges 20% on Growth Forecast | NASDAQ:MRNA | Moderna Inc |
| 12/09/2024 | 11:45 | PR Newswire (US) | Moderna, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRNA | NASDAQ:MRNA | Moderna Inc |
| 10/09/2024 | 13:30 | PR Newswire (US) | Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases | NASDAQ:MRNA | Moderna Inc |
| 09/09/2024 | 16:26 | PR Newswire (US) | Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join - Contact The Gross Law Firm | NASDAQ:MRNA | Moderna Inc |
| 05/09/2024 | 11:45 | PR Newswire (US) | Moderna, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA | NASDAQ:MRNA | Moderna Inc |
| 26/08/2024 | 11:45 | PR Newswire (US) | Class Action Filed Against Moderna, Inc. (MRNA) Seeking Recovery for Investors - Contact The Gross Law Firm | NASDAQ:MRNA | Moderna Inc |
| 23/08/2024 | 14:20 | IH Market News | Cruise and Uber Join Forces for Robotaxis, Alibaba Shifts Primary Listing to Hong Kong, Altria Hikes Dividend 4.1% | NASDAQ:MRNA | Moderna Inc |
| 22/08/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 8, 2024 in Moderna, Inc. Lawsuit - MRNA | NASDAQ:MRNA | Moderna Inc |
| 15/08/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Notifies Shareholders of Moderna, Inc.(MRNA) of a Class Action Lawsuit and an Upcoming Deadline | NASDAQ:MRNA | Moderna Inc |
| 06/08/2024 | 12:30 | PR Newswire (US) | Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner | NASDAQ:MRNA | Moderna Inc |
| 01/08/2024 | 15:07 | IH Market News | Futures Pointing To Continued Strength On Wall Street | NASDAQ:MRNA | Moderna Inc |
| 30/07/2024 | 12:03 | IH Market News | F5 Shares Rise 15%; Diageo Falls 10% on Annual Sales Decline; BP Boosts Dividend and Buyback Program | NASDAQ:MRNA | Moderna Inc |
| 03/07/2024 | 12:59 | IH Market News | Apple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More News | NASDAQ:MRNA | Moderna Inc |